Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer

NCT05640609 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Stomach Neoplasm

Interventions

COMBINATION_PRODUCT: Capeox regimen combined with Sintilimab and Bevacizumab

Sponsor

West China Hospital